Advertisement
Research Article| Volume 11, ISSUE 3, P346-353, May 1991

Glomerular crescent formation

  • Lawrence B. Holzman
    Affiliations
    From the Division of Nephrology, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI, USA
    Search for articles by this author
  • Roger C. Wiggins
    Correspondence
    Address reprint requests to Roger C. Wiggins, MD, Division of Nephrology, Department of Internal Medicine, University of Michigan Medical School, 3914 Taubman Center, Ann Arbor, MI 48109-0364.
    Affiliations
    From the Division of Nephrology, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI, USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Seminars in Nephrology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Salant D.J.
        Immunopathogenesis of crescentic glomerulonephritis and lung purpura.
        Kidney Int. 1987; 32: 408-425
        • Wiggins R.C.
        • Glatfelter A.
        • Brukman J.
        Procoagulant activity in glomeruli and urine of rabbits with nephrotoxic nephritis.
        Lab Invest. 1985; 53: 156-165
        • Silva F.G.
        • Hoyer J.R.
        • Pirani C.L.
        Sequential studies of glomerular crescent formation in rats with antiglomerular basement membrane-induced glomerulonephritis and the role of coagulation factors.
        Lab Invest. 1984; 51: 404-415
        • Morita T.
        • Suzuki Y.
        • Churg J.
        Structure and development of the glomerular crescent.
        Am J Pathol. 1973; 72: 349-358
        • Naish P.F.
        • Thomson N.M.
        • Simpson U.
        • et al.
        The role of polymorphonuclear leukocytes in the autologous phase of nephrotoxic nephritis.
        Clin Exp Immunol. 1975; 22: 102-111
        • Atkins R.C.
        • Holdsworth S.R.
        • Glascow E.F.
        • et al.
        The macrophage in rapidly progressive glomerulonephritis.
        Lancet. 1976; 1: 830-835
        • Magil A.B.
        • Wadsworth L.D.
        Monocytes in human glomerulonephritis.
        Lab Invest. 1981; 45: 77-81
        • Cattell V.
        • Jamieson S.W.
        The origin of glomerular crescents in experimental nephrotoxic serum nephritis in the rabbit.
        Lab Invest. 1978; 39: 584-590
        • Eldridge C.
        • Wiggins R.C.
        T cells in the glomerulus, periglomerular region and around venules early in crescentic nephritis in the rabbit. Evidence for glomerulo-interstitial signals.
        Kidney Int. 1987; 31 (abstr): 318
        • Alpers C.E.
        • Cotran R.S.
        Neoplasia and glomerular injury.
        Kidney Int. 1986; 30: 465-473
        • Holzman L.B.
        • Wiggins R.C.
        Thrombospondin is transiently expressed during early crescent formation in a model of crescentic glomerulonephritis.
        Kidney Int. 1990; 37 (abstr): 416
        • Magil A.B.
        Histiogenesis of glomerular crescents.
        Am J Pathol. 1985; 120: 222-229
        • Striker L.J.
        • Killen P.D.
        • Chi E.
        • et al.
        The composition of glomerulosclerosis.
        Lab Invest. 1984; 51: 181-192
        • Merritt S.E.
        • Killen P.D.
        • Phan S.H.
        • et al.
        Analysis of a1(I) procollagen, al(IV) collagen, and β-actin mRNA in glomerulus and cortex of rabbits with experimental anti-glomerular basement membrane disease. Evidence for early extraglomerular collagen biosynthesis.
        Lab Invest. 1990; 63: 762-769
        • Tipping P.G.
        • Neale T.J.
        • Holdsworth S.R.
        T lymphocyte participation in antibody induced experimental glomerulonephritis.
        Kidney Int. 1985; 27: 530-537
        • Downer G.
        • Phan S.H.
        • Wiggins R.C.
        Analysis of renal fibrosis in a rabbit model of crescentic nephritis.
        J Clin Invest. 1988; 82: 998-1006
        • Postlewaite A.E.
        • Smith G.N.
        • Mainardi C.L.
        • et al.
        Lymphocyte modulation of fibroblast function in vitro: Stimulation and inhibition of collagen production by different effector molecules.
        J Immunol. 1984; 132: 2470-2477
        • Neilson E.G.
        • Jimenez S.A.
        • Phillips S.M.
        Cell mediated immunity in interstitial nephritis.
        J Immunol. 1980; 125: 1708-1714
        • Springer T.A.
        Adhesion receptors of the immune system.
        Nature. 1990; 346: 425-434
        • Montovani A.
        • Dejana L.
        Cytokines as communication signals between leukocytes and endothelial cells.
        Immunol Today. 1989; 10: 370-375
        • Swenson C.L.
        • Chapo J.A.
        • Grande J.P.
        • et al.
        Tumor necrosis factor induces expression of macrophage chemotactic and activating factor by human mesangial cells.
        J Am Soc Nephrol. 1990; 1 (abstr): 732
        • Adams D.O.
        • Hamilton T.A.
        The cell biology of macrophage activation.
        Ann Rev Immunol. 1984; 2: 283-318
        • Fantone J.C.
        • Ward P.A.
        Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions.
        Am J Pathol. 1982; 107: 397-418
        • di Giovine F.S.
        • Duff G.W.
        Interleukin 1: The first interleukin.
        Immunol Today. 1990; 4: 13-20
        • Beutler B.
        • Cerami A.
        Cachectin: More than a tumor necrosis factor.
        N Engl J Med. 1987; 316: 379-385
        • Kunkel S.L.
        • Strieter R.M.
        • Chensue S.W.
        • et al.
        Tumor necrosis factor-alpha, interleukin-8 and chemotactic cytokines.
        Prog Clin Biol Res. 1990; 349: 433-444
        • Strieter R.M.
        • Kunkel S.L.
        • Showell H.J.
        • et al.
        Endothelial cell gene expression of a neutrophil chemotactic factor by TNF α, LPS, and IL-1 beta.
        Science. 1989; 243: 1467-1469
        • Bevilacqua M.P.
        • Pober J.S.
        • Wheeler M.E.
        • et al.
        Interleukin 1 acts on cultured human vascular endothelium to increase adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.
        J Clin Invest. 1985; 76: 2003-2011
        • Libby P.S.
        • Warner J.C.
        • Friedman G.B.
        Interleukin I: A mitogen that induces the release of growth-inhibitory prostanoids.
        J Clin Invest. 1988; 81: 487-498
        • Naish P.
        • Penn G.B.
        • Evans D.J.
        • et al.
        The effect of defibrination on nephrotoxic serum nephritis in rabbits.
        Clin Sci. 1972; 42: 643-646
        • Thomson N.M.
        • Moran J.
        • Simpson I.J.
        • et al.
        Definition with anacrod in nephrotoxic nephritis in rabbits.
        Kidney Int. 1976; 10: 343-347
        • Bevilacqua M.P.
        • Pober J.S.
        • Majeau G.R.
        • et al.
        Recombinant tumor necrosis factor induces procoagulant activity in cultured vascular endothelium: Characterization and comparison with actions of interleukin 1.
        in: Proc Natl Acad Sci USA. 83. 1986: 4533-4537
        • Nawroth P.P.
        • Stern D.M.
        Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
        J Exp Med. 1986; 163: 740-745
        • Schlee R.R.
        • Bevilacqua M.P.
        • Sawdey M.
        • et al.
        Cytokine activation of vascular endothelium. Effects on tissue type plasminogen activator and type 1 plasminogen activator inhibitor.
        J Biol Chem. 1988; 263: 5797-5803
        • Edwards R.L.
        • Rickles F.R.
        • Bobrove A.M.
        Mononuclear cell tissue factor: Cells of origin and requirements for activation.
        Blood. 1979; 54: 359-370
        • Drake T.A.
        • Morrissey J.H.
        • Edgington T.S.
        Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.
        Am J Pathol. 1989; 134: 1087-1097
        • Holdsworth S.R.
        • Tipping P.G.
        Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit.
        J Clin Invest. 1985; 76: 1367-1374
        • Mayer M.
        Biochemical and biological aspects of the plasminogen activation system.
        Clin Biochem. 1990; 23: 197-211
        • Labat-Robert J.
        • Bihari-Varga M.
        • Robert L.
        Extracellular matrix.
        FEBS Lett. 1990; 268: 386-393
        • Bruijin J.A.
        • Hogendoorn P.C.W.
        • Hoedemaeker P.J.
        • et al.
        The extracellular matrix in pathology.
        J Lab Clin Med. 1988; 111: 140-190
        • Cybulsky A.V.
        • Bonventre J.V.
        • Quigg R.G.
        • et al.
        Extracellular matrix regulates proliferation and phospholipid turnover in glomerular epithelial cells.
        Am J Physiol. 1990; 259: F326-F337
        • Person J.M.
        • Lovett D.H
        • Raugi G.J.
        Modulation of mesangial cell migration by extracellular matrix components. Inhibition by heparin-like glycosaminoglycans.
        Am J Pathol. 1988; 133: 609-614
        • Klein D.J.
        • Brown D.M.
        • Kim Y.
        • et al.
        Proteoglycans synthesized by human glomerular mesangial cells in culture.
        J Biol Chem. 1990; 265: 9533-9543
        • Border W.A.
        • Okuda S.
        • Languine L.I.Z.
        • et al.
        Transferring growth factor β regulates production of proteoglycans by mesangial cells.
        Kidney Int. 1990; 32: 514-525
        • Okuda S.
        • Languino L.R.
        • Ruoslahti E.
        • et al.
        Elevated expression of transforming growth factor β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of mesangial extracellular matrix.
        J Clin Invest. 1990; 86: 453-462
        • Foellmer H.G.
        • Sterzel R.B.
        • Kashgarian M.
        Progressive glomerular sclerosis in experimental antiglomerular basement membrane glomerulonephritis.
        Am J Kidney Dis. 1986; 7: 5-11
        • Adler S.
        • Striker L.J.
        • Striker G.E.
        • et al.
        Studies of progressive glomerular sclerosis in the rat.
        Am J Pathol. 1986; 123: 553-562
        • McClurkin C.
        • Phan S.H.
        • Hsu C.
        • et al.
        Moderate protection of renal function and reduction of fibrosis by colchicine in a model of anti-GBM disease in the rabbit.
        J Am Soc Nephrol. 1990; 1: 257-260
        • Werb Z.
        • Barda M.
        • Jones P.
        Degradation of connective tissue matrices by macrophages.
        J Exp Med. 1980; 152: 1340-1357
        • Harris E.D.
        • Welgus H.
        • Krane S.
        Regulation of the mammalian collagenases.
        Coll Rel Res. 1984; 4: 493-582
        • Murphy G.
        • Reynolds J.J.
        • Werb Z.
        Biosynthesis of tissue inhibitor of metaloproteinases by human fibroblasts in culture.
        J Biol Chem. 1985; 260: 3079-3083
        • Davies M.
        • Thomas G.J.
        • Martin J.
        • et al.
        The purification and characterization of a glomerular basement-membrane-degrading neutral proteinase from rat mesangial cells.
        Biochem J. 1988; 251: 419-425
        • Martin J.
        • Davies M.
        • Thomas G.J.
        • et al.
        Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor.
        Kidney Int. 1989; 36: 790-801
        • Lovett D.H.
        • Szamel M.
        • Ryan J.L.
        • et al.
        Interleukin I and the glomerular mesangium. I. Purification and characterization of a mesangial cell-derived autogrowth factor.
        J Immunol. 1986; 137: 525-532
        • Wahl S.M.
        • Hunt D.A.
        • Wakefield L.M.
        • et al.
        Transforming growth factor type β induces monocyte chemotaxis and growth factor production.
        in: Proc Natl Acad Sci USA. 84. 1987: 5788-5792
        • Postlethwaite A.E.
        • Keski-Oja J.
        • Moses H.L.
        • et al.
        Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β.
        J Exp Med. 1987; 165: 251-256
        • Hill D.J.
        • Strain A.J.
        • Elston S.F.
        • et al.
        Bi-functional action of transforming growth factor β on DNA synthesis in early passage human fetal fibroblasts.
        J Cell Physiol. 1986; 128: 322-328
        • MacKay K.
        • Striker L.J.
        • Stauffer J.W.
        • et al.
        Transforming growth factor-β. Murine glomerular receptors and responses of isolated glomerular cells.
        J Clin Invest. 1989; 83: 1160-1167
        • Edwards D.R.
        • Murphy G.
        • Reynolds J.J.
        • et al.
        Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.
        EMBO J. 1987; 6: 1899-1904
        • Coimbra T.
        • Wiggins R.C.
        • Noh J.W.
        • et al.
        Transforming growth factor-β production in anti-glomerular membrane disease in the rabbit.
        Am J Pathol. 1990; 138: 223-234
        • Border W.A.
        • Okuda S.
        • Languine L.R.
        • et al.
        Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1.
        Nature. 1990; 346: 371-374
        • Couser W.G.
        Rapidly progressive glomerulonephritis: Classification, pathogenetic mechanisms, and therapy.
        Am J Kidney Dis. 1988; 11: 449-464
        • Bennett W.M.
        • Kincaid-Smith P.
        Macroscopic haematuria in mesangial IgA nephropathy.
        Kidney Int. 1983; 23: 393-400
        • Hind C.R.K.
        • Lockwood C.M.
        • Peters D.K.
        • et al.
        Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis.
        Lancet. 1983; 1: 263-265